09 March 2020
: Case report
Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert
Unusual or unexpected effect of treatment, Adverse events of drug therapy
John M. Cunningham12EF*, Katherine V. Sachs12EF, Rebecca Allyn12EFDOI: 10.12659/AJCR.921643
Am J Case Rep 2020; 21:e921643
Abstract
BACKGROUND: Cefepime-induced neurotoxicity has been described in intensive care units (ICUs) and neuro ICU settings, occurring in patients started on cefepime for management of severe infections and sepsis. Most cases occur within 1 to 10 days after starting the drug. We publish a case that occurred on the general medical ward of a patient who had been on cefepime therapy for 4 weeks prior to admission. The aim of this study was to improve the knowledge of this serious condition to general internists as our patient was being managed on the general medical ward.
CASE REPORT: A 72-year-old female on prolonged intravenous antibiotics for sacral and pelvic osteomyelitis presented with acute encephalopathy and aphasia in the setting of an acute kidney injury. Due to the acute focal neurologic deficit, she was initially admitted as a stroke alert. After a negative magnetic resonance imaging (MRI) of the brain, an electroencephalogram (EEG) was pursued and showed nonconvulsive status epilepticus (NCSE). NCSE was likely a result of cefepime therapy in the setting of an acute kidney injury.
CONCLUSIONS: Cefepime-induced neurotoxicity should be suspected in any patient on cefepime therapy who develops acute changes in mental status, myoclonus, or evidence of seizures. Risk factors for the disease include older age, renal dysfunction, critical illness, and inappropriate dosing based upon renal function. A high index of suspicion is required and delays in diagnosis are common as there are frequently multiple possible causes for altered mental status in systemically ill patients requiring treatment with broad-spectrum antibiotics.
Keywords: Aphasia, cephalosporins, Epilepsy, Generalized, Neurotoxicity Syndromes, Acute Kidney Injury, Aged, Anti-Bacterial Agents, Anticonvulsants, Brain Diseases, cefepime, Levetiracetam, Lorazepam, osteomyelitis, Status epilepticus
1734 31
Editorial
01 October 2023 : Editorial
Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air PollutionDOI: 10.12659/MSM.942672
Med Sci Monit 2023; 29:e942672
In Press
04 Oct 2023 : Clinical Research
A Retrospective Study of 205 Patients with Complex Kidney Stones to Compare Outcomes from Super-Mini Percut...Med Sci Monit In Press; DOI: 10.12659/MSM.941012
03 Oct 2023 : Clinical Research
Prevalence and Risk Factors for Modic Changes in Symptomatic Cervical Ossification of the Posterior Longitu...Med Sci Monit In Press; DOI: 10.12659/MSM.941674
03 Oct 2023 : Clinical Research
Time-Dependent Factors Influencing Cardiocerebral Vascular Events in Chronic Hemodialysis Patients: Insight...Med Sci Monit In Press; DOI: 10.12659/MSM.941553
02 Oct 2023 : Clinical Research
Comparison of Nanocrystalline Hydroxyapatite Bone Graft with Empty Defects in Long Bone Fractures: A Retros...Med Sci Monit In Press; DOI: 10.12659/MSM.941112
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292